You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Neil Versel is an editor at GenomeWeb. He covers the life science and healthcare informatics markets.
Multinational nephrology firm Fresenius Medical Care eventually wants as many as 200,000 samples in its registry and aims to sequence 20,000 patients this year.
By extending Terra to the Microsoft Azure cloud, the Broad and Verily Life Sciences hope to facilitate better data sharing, analysis, and reuse.
The early-stage company just launched a bioinformatics security service, but it is developing technology to label and manage individual molecules in DNA samples.
The Gene Curation Coalition, led by the Broad Institute, is serving as a clearinghouse of sorts for curated datasets on Mendelian disorders.
The Dutch bioinformatics firm's ImmunoGenomiX technology platform is helping researchers develop therapies for COVID-19 as well as for cancer.
NHGRI has moved the Genotype-Tissue Expression dataset entirely to the cloud in an effort to democratize access to the huge but formerly pricey compendium.
Some are comparing iGenomics, a former high school intern's creation, to the fictional "medical tricorder" of "Star Trek" fame.
By chopping RNA-seq reads into smaller bits, UW-Tacoma data scientists are able to cut the alignment step to one minute, but the approach has skeptics.
San Francisco Otolaryngology hopes that 2bPrecise's PGx technology can help manage the medication burden on older patients and improve symptoms of dementia.
Developed by Lausanne University Hospital and presented at AMIA, the technology simulates malicious attacks on personal genomic data to risk scores for specific disclosures.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.